Treace Medical Concepts, Inc. (TMCI) Tops Q3 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $45.08 million versus the consensus estimate of $43.48 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• LivePerson adjourns stockholder vote on SoundHound AI merger to Sept. 2
• Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy